Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotechnology Value Fund, L.P. -- Ignore unavailable to you. Want to Upgrade?

To: scaram(o)uche who wrote (373)	12/24/1998 1:33:00 PM
From: scaram(o)uche	Read Replies (1) \| Respond to of 4974

GLFD filing from today......... ITEM 3. SOURCE AND AMOUNT OF FUNDS OR OTHER CONSIDERATION. Since October 9, 1998, Partners, in its capacity as general partner of BVF, has purchased on behalf of such limited partnership an aggregate number of 1,750 shares of the Stock for an aggregate consideration of $27,428.78, utilizing funds provided by BVF from its working capital pursuant to the terms of its limited partnership agreement with Partners, and sold an aggregate number of 62,200 shares of the Stock for an aggregate consideration of $852,566.43. In addition, Partners, in its capacity as investment manager with respect to certain managed accounts, has purchased on behalf of such managed accounts an aggregate number of 750 shares of the Stock for an aggregate consideration of $11,678.78, utilizing funds under management by Partners pursuant to investment management agreements between Partners and such managed accounts, and sold an aggregate number of 172,100 shares of the Stock for an aggregate consideration of $2,327,984.23. ***************** So, pretty much the same story..... selling an interest in a company that they like, IMO.